Serial 97229576
Live / Registered — Registered (as of 05 Dec 2023)
What this means for you
Registered since 05 Dec 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97229576
- Registration number
- 7237458
- Mark type
- Design / logo
- Filed
- 20 Jan 2022
- Published for opposition
- 09 Aug 2022
- Registered
- 05 Dec 2023
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 042 — Scientific and technological services: research and development in the pharmaceutical and biotechnology fields; research and development of pharmaceuticals for the treatment of cancer; research and development of medicines; consulting services in the fields of biotechnology, pharmaceutical research and development, and genetic science; consulting services in the fields of biotechnology, pharmaceutical research and development, and pharmacogenetics; medical and scientific research in the field of cancer treatment and diagnosis; medical research services in the field of cancer; pharmaceutical research and development; providing laboratory research services in the field of gene expression, namely, cancer biology; scientific research for medical purposes in the area of cancerous diseases; scientific research for medical purposes in the field of cancer and acute and chronic devastating diseases and conditions beyond cancer; stem cell research services; testing, inspection, research, or development of pharmaceutical preparations for gene therapy
Owner
- ElevateBio, LLC, Cambridge, MA, US
- ElevateBio, LLC, Cambridge, MA, US
- ElevateBio, LLC, Cambridge, MA, US
Prior registrations
Prosecution history
- 05 Dec 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Dec 2023 — REGISTERED-PRINCIPAL REGISTER
- 31 Oct 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 30 Oct 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Oct 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 13 Oct 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Oct 2023 — USE AMENDMENT FILED
- 13 Oct 2023 — SOU EXTENSION 2 GRANTED
- 03 Oct 2023 — SOU EXTENSION 2 FILED
- 13 Oct 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Oct 2023 — SOU TEAS EXTENSION RECEIVED
- 03 Oct 2023 — TEAS STATEMENT OF USE RECEIVED
- 01 Apr 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 30 Mar 2023 — SOU EXTENSION 1 GRANTED
- 30 Mar 2023 — SOU EXTENSION 1 FILED